GOSERELIN

GOSERELIN was reported 13570 times

GOSERELIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYP3A4 POLYMORPHISM 10 0.8333
1 CENTRAL NERVOUS SYSTEM MASS 51 0.5368
2 MALIGNANT SPINAL CORD COMPRESSION 22 0.5238
3 WALL MOTION SCORE INDEX ABNORMAL 51 0.4636
4 AIRWAY REMODELLING 51 0.4113
5 MUCINOUS BREAST CARCINOMA 11 0.2821
6 ATOPY 51 0.1835
7 PIK3CA-ACTIVATED MUTATION 55 0.1657
8 EXPULSION OF MEDICATION 70 0.1323
9 ULTRASOUND FOETAL ABNORMAL 11 0.1310
10 METASTASES TO SPINAL CORD 23 0.1186
11 METASTASES TO NERVOUS SYSTEM 17 0.0924
12 PLEURAL NEOPLASM 13 0.0788
13 OOPHORECTOMY BILATERAL 12 0.0779
14 EOSINOPHILIC MYOCARDITIS 51 0.0699
15 BODY SURFACE AREA INCREASED 9 0.0698
16 CARBOHYDRATE ANTIGEN 15-3 INCREASED 52 0.0683
17 CARDIAC SEPTAL DEFECT 49 0.0682
18 METASTASES TO OVARY 19 0.0596
19 MICROANGIOPATHY 51 0.0543
20 CARCINOID TUMOUR PULMONARY 13 0.0539
21 METASTASES TO PELVIS 34 0.0538
22 METASTASES TO THE MEDIASTINUM 22 0.0534
23 METASTASES TO SKIN 50 0.0484
24 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 16 0.0482
25 DILATATION INTRAHEPATIC DUCT ACQUIRED 14 0.0479
26 HORMONE RECEPTOR POSITIVE BREAST CANCER 13 0.0478
27 INVASIVE LOBULAR BREAST CARCINOMA 23 0.0448
28 OESTRADIOL DECREASED 14 0.0435
29 OESTRADIOL INCREASED 13 0.0432
30 METASTASES TO BONE 707 0.0430
31 INVASIVE BREAST CARCINOMA 17 0.0412
32 METASTASES TO EYE 9 0.0411
33 ABDOMINAL LYMPHADENOPATHY 35 0.0403
34 METASTASES TO SPINE 129 0.0383
35 ADNEXA UTERI MASS 11 0.0381
36 PROSTATE CANCER METASTATIC 116 0.0347
37 METASTASES TO PLEURA 36 0.0343
38 BONE MARROW INFILTRATION 13 0.0336
39 PITUITARY HAEMORRHAGE 10 0.0323
40 HER2 POSITIVE BREAST CANCER 12 0.0320
41 METASTASES TO CHEST WALL 10 0.0288
42 FIBROUS HISTIOCYTOMA 10 0.0285
43 PROSTATE CANCER RECURRENT 17 0.0276
44 METASTASES TO LIVER 451 0.0256
45 METASTASES TO STOMACH 10 0.0255
46 ARTERIAL INJURY 19 0.0254
47 BREAST CANCER METASTATIC 273 0.0254
48 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 51 0.0250
49 METASTASES TO ADRENALS 23 0.0249
50 BONE LESION 87 0.0241
51 WOUND DEBRIDEMENT 10 0.0239
52 EOSINOPHIL COUNT DECREASED 57 0.0239
53 OSTEOLYSIS 47 0.0230
54 PRIMARY SEQUESTRUM 20 0.0221
55 METASTASES TO LYMPH NODES 149 0.0221
56 METASTASES TO BONE MARROW 11 0.0220
57 PHARMACEUTICAL NOMADISM 11 0.0215
58 BLOOD IMMUNOGLOBULIN E INCREASED 51 0.0210
59 OSTEOSCLEROSIS 33 0.0209
60 BONE DEBRIDEMENT 10 0.0207
61 PLEURAL DISORDER 13 0.0207
62 EOSINOPHILIC PNEUMONIA 65 0.0206
63 PROSTATIC SPECIFIC ANTIGEN INCREASED 284 0.0206
64 BREAST CANCER MALE 10 0.0196
65 RESPIRATORY SYMPTOM 55 0.0193
66 MENOPAUSAL SYMPTOMS 45 0.0193
67 INVASIVE DUCTAL BREAST CARCINOMA 52 0.0191
68 TUMOUR FLARE 13 0.0190
69 BLOOD OESTROGEN INCREASED 11 0.0187
70 PO2 INCREASED 9 0.0178
71 METASTASES TO PERITONEUM 44 0.0174
72 ABDOMINAL INJURY 9 0.0172
73 DEVICE SAFETY FEATURE ISSUE 17 0.0172
74 TRANSAMINASES ABNORMAL 10 0.0172
75 VENTRICULAR HYPOKINESIA 55 0.0171
76 METASTASES TO LUNG 195 0.0169
77 ASEPTIC NECROSIS BONE 13 0.0166
78 TUMOUR MARKER INCREASED 78 0.0162
79 BREAST CANCER RECURRENT 51 0.0161
80 PLEURAL THICKENING 11 0.0161
81 LEIOMYOMA 11 0.0158
82 ENDOMETRIAL HYPERPLASIA 12 0.0148
83 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 15 0.0145
84 CHRONIC SINUSITIS 54 0.0144
85 BLADDER IRRITATION 9 0.0140
86 PULMONARY HYPOPLASIA 11 0.0140
87 HILAR LYMPHADENOPATHY 12 0.0136
88 SEQUESTRECTOMY 9 0.0135
89 MALIGNANT NEOPLASM PROGRESSION 1367 0.0133
90 INHIBITORY DRUG INTERACTION 21 0.0133
91 MALIGNANT ASCITES 10 0.0130
92 OVARIAN DISORDER 12 0.0128
93 HORMONE-REFRACTORY PROSTATE CANCER 15 0.0126
94 INTERVERTEBRAL DISC SPACE NARROWING 10 0.0124
95 LYMPHADENOPATHY MEDIASTINAL 23 0.0120
96 ABSCESS JAW 12 0.0115
97 METASTASES TO MENINGES 26 0.0114
98 LYMPHANGITIS 9 0.0112
99 ALANINE AMINOTRANSFERASE DECREASED 8 0.0110
100 HYDROTHORAX 9 0.0108
101 BREAST MASS 72 0.0107
102 BLOOD TESTOSTERONE INCREASED 23 0.0107
103 PERIODONTITIS 23 0.0106
104 EXPOSED BONE IN JAW 23 0.0106
105 NASAL POLYPS 52 0.0105
106 NEUTROPENIC INFECTION 10 0.0104
107 HEPATIC MASS 20 0.0104
108 METASTASIS 74 0.0104
109 PCO2 DECREASED 10 0.0104
110 HEPATIC LESION 44 0.0102
111 OOPHORECTOMY 9 0.0101
112 BILE DUCT STENOSIS 12 0.0100
113 DECREASED IMMUNE RESPONSIVENESS 98 0.0100
114 PREMATURE MENOPAUSE 9 0.0097
115 ABDOMINAL WALL HAEMATOMA 19 0.0097
116 GASTROINTESTINAL BACTERIAL INFECTION 11 0.0096
117 PARAPARESIS 17 0.0095
118 CANCER PAIN 24 0.0094
119 METASTASES TO CENTRAL NERVOUS SYSTEM 121 0.0094
120 BONE SWELLING 9 0.0093
121 BONE NEOPLASM 10 0.0093
122 METASTATIC NEOPLASM 40 0.0093
123 PATHOLOGICAL FRACTURE 47 0.0093
124 LYMPHOEDEMA 63 0.0091
125 BREAST SWELLING 24 0.0089
126 INTRA-ABDOMINAL HAEMATOMA 11 0.0089
127 BREAST NEOPLASM 9 0.0087
128 OSTEONECROSIS OF JAW 210 0.0085
129 BLOOD ALKALINE PHOSPHATASE DECREASED 8 0.0084
130 OSTEITIS 21 0.0083
131 PITUITARY TUMOUR BENIGN 13 0.0080
132 ACUTE PROMYELOCYTIC LEUKAEMIA 8 0.0078
133 CARCINOEMBRYONIC ANTIGEN INCREASED 15 0.0077
134 VULVOVAGINAL DRYNESS 25 0.0077
135 OVARIAN HYPERSTIMULATION SYNDROME 18 0.0077
136 MEAN CELL HAEMOGLOBIN INCREASED 12 0.0072
137 UTERINE POLYP 13 0.0072
138 SPINAL CORD COMPRESSION 28 0.0072
139 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 17 0.0072
140 HEPATIC CYST 24 0.0071
141 MEAN CELL VOLUME INCREASED 18 0.0070
142 HOT FLUSH 527 0.0070
143 ACQUIRED GENE MUTATION 9 0.0069
144 GENE MUTATION 13 0.0066
145 MALIGNANT PLEURAL EFFUSION 11 0.0065
146 NEOPLASM RECURRENCE 22 0.0065
147 EOSINOPHIL COUNT INCREASED 54 0.0065
148 BONE CANCER 28 0.0064
149 NEOPLASM PROGRESSION 213 0.0061
150 BONE DISORDER 111 0.0061
151 MENTAL FATIGUE 9 0.0060
152 AORTIC ARTERIOSCLEROSIS 15 0.0058
153 HAEMATOTOXICITY 55 0.0058
154 TRIGGER FINGER 23 0.0056
155 JAW FRACTURE 12 0.0056
156 SPINAL PAIN 65 0.0055
157 URINARY TRACT OBSTRUCTION 13 0.0055
158 SPINAL CORD DISORDER 9 0.0055
159 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
160 OLIGOHYDRAMNIOS 18 0.0054
161 DEPRESSIVE SYMPTOM 19 0.0054
162 TERMINAL STATE 36 0.0054
163 OBSTRUCTIVE AIRWAYS DISORDER 59 0.0053
164 HYPOPROTEINAEMIA 10 0.0053
165 BLOOD PH DECREASED 9 0.0053
166 BILIARY COLIC 15 0.0052
167 RECURRENT CANCER 21 0.0051
168 HORMONE LEVEL ABNORMAL 25 0.0051
169 LYMPHOPENIA 72 0.0051
170 NODULE 66 0.0051
171 NEUTROPENIA 680 0.0050
172 INTERNATIONAL NORMALISED RATIO ABNORMAL 17 0.0049
173 PURULENT DISCHARGE 21 0.0049
174 BREAST DISORDER 10 0.0049
175 MASTICATION DISORDER 15 0.0049
176 MYELOSUPPRESSION 176 0.0049
177 BREAST PAIN 52 0.0049
178 BILIRUBIN CONJUGATED INCREASED 11 0.0047
179 RADIOTHERAPY 9 0.0047
180 MENOPAUSE 12 0.0047
181 BREAST ENLARGEMENT 15 0.0046
182 RADICULOPATHY 12 0.0045
183 SKIN FRAGILITY 11 0.0045
184 OSTEOMYELITIS 81 0.0045
185 LUMBAR SPINAL STENOSIS 13 0.0044
186 HEPATOTOXICITY 97 0.0044
187 HAEMORRHAGE URINARY TRACT 11 0.0043
188 CEREBRAL ATROPHY 17 0.0043
189 PAPILLOEDEMA 19 0.0042
190 INTRA-ABDOMINAL HAEMORRHAGE 10 0.0042
191 OBESITY 66 0.0041
192 COMPRESSION FRACTURE 22 0.0041
193 UTERINE LEIOMYOMA 30 0.0041
194 BLOOD ALKALINE PHOSPHATASE INCREASED 101 0.0041
195 HYPOPHOSPHATAEMIA 30 0.0041
196 HAEMATURIA 138 0.0040
197 PULMONARY MASS 60 0.0040
198 TOOTH EXTRACTION 50 0.0040
199 JAW DISORDER 22 0.0040
200 NEUTROPHIL COUNT DECREASED 163 0.0040
201 BLOOD TESTOSTERONE DECREASED 27 0.0039
202 BONE PAIN 230 0.0039
203 CHOLANGITIS SCLEROSING 8 0.0039
204 GINGIVITIS 21 0.0039
205 DIVERTICULUM INTESTINAL 17 0.0039
206 ASCITES 114 0.0039
207 GINGIVAL SWELLING 17 0.0038
208 VITILIGO 9 0.0038
209 PARAPLEGIA 11 0.0038
210 OSTEONECROSIS 123 0.0037
211 HYDRONEPHROSIS 28 0.0037
212 PROTEIN TOTAL DECREASED 14 0.0037
213 SPINAL COMPRESSION FRACTURE 30 0.0036
214 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
215 HEPATIC CYTOLYSIS 46 0.0036
216 NAIL DISORDER 31 0.0035
217 BLOOD BILIRUBIN INCREASED 95 0.0035
218 HEPATIC NECROSIS 13 0.0034
219 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 22 0.0034
220 HEPATIC NEOPLASM 11 0.0034
221 INTERSTITIAL LUNG DISEASE 162 0.0033
222 ONYCHOCLASIS 23 0.0033
223 LYMPHADENOPATHY 116 0.0033
224 LUMBAR VERTEBRAL FRACTURE 15 0.0033
225 JAUNDICE 88 0.0033
226 SECOND PRIMARY MALIGNANCY 27 0.0032
227 OCULAR ICTERUS 14 0.0032
228 HEPATIC ENZYME ABNORMAL 16 0.0032
229 SKIN HYPERTROPHY 9 0.0032
230 CHOLECYSTITIS ACUTE 18 0.0032
231 BREAST CANCER STAGE IV 9 0.0032
232 HEPATIC FUNCTION ABNORMAL 118 0.0032
233 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
234 ENDOMETRIOSIS 15 0.0031
235 LEUKOPENIA 157 0.0031
236 HYPOCALCAEMIA 59 0.0031
237 ALANINE AMINOTRANSFERASE INCREASED 191 0.0031
238 PLEURAL EFFUSION 189 0.0031
239 ATELECTASIS 30 0.0031
240 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
241 AORTIC VALVE INCOMPETENCE 13 0.0031
242 POTENTIATING DRUG INTERACTION 10 0.0030
243 ASPARTATE AMINOTRANSFERASE INCREASED 158 0.0030
244 PNEUMONITIS 80 0.0029
245 MUSCULOSKELETAL CHEST PAIN 45 0.0029
246 HAIR GROWTH ABNORMAL 20 0.0029
247 FAECES SOFT 21 0.0029
248 DISEASE PROGRESSION 336 0.0028
249 ELECTROCARDIOGRAM QT PROLONGED 102 0.0028
250 JAUNDICE CHOLESTATIC 10 0.0028
251 FIBRIN D DIMER INCREASED 10 0.0028
252 HEPATIC PAIN 12 0.0028
253 ANAL FISSURE 15 0.0028
254 AMENORRHOEA 49 0.0028
255 LOOSE TOOTH 9 0.0028
256 PERFORMANCE STATUS DECREASED 13 0.0028
257 MENSTRUAL DISORDER 23 0.0028
258 DERMATITIS 58 0.0028
259 BLOOD PHOSPHORUS DECREASED 10 0.0027
260 MUCOSAL INFLAMMATION 71 0.0027
261 GASTROINTESTINAL TOXICITY 13 0.0027
262 PROSTATE CANCER 216 0.0027
263 LACRIMATION INCREASED 81 0.0027
264 WOUND DEHISCENCE 9 0.0027
265 NEUTROPENIC SEPSIS 19 0.0027
266 BREAST CANCER 243 0.0026
267 OVARIAN CYST 26 0.0026
268 HAEMATOCRIT DECREASED 51 0.0026
269 LOSS OF LIBIDO 23 0.0026
270 SPINAL COLUMN STENOSIS 12 0.0025
271 HAEMORRHAGE SUBCUTANEOUS 9 0.0025
272 WHITE BLOOD CELL COUNT DECREASED 274 0.0025
273 HYPERCALCAEMIA 31 0.0025
274 INTERMENSTRUAL BLEEDING 14 0.0025
275 SPINAL OSTEOARTHRITIS 22 0.0025
276 RESPIRATORY TRACT INFECTION 65 0.0025
277 BLOOD CALCIUM DECREASED 28 0.0025
278 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
279 HEPATIC STEATOSIS 46 0.0025
280 AMYLASE INCREASED 9 0.0024
281 MYOPATHY 21 0.0024
282 MADAROSIS 28 0.0024
283 LEFT VENTRICULAR DYSFUNCTION 16 0.0024
284 MUSCLE ATROPHY 30 0.0024
285 THYROID MASS 9 0.0023
286 LUNG NEOPLASM 10 0.0023
287 GINGIVAL DISORDER 9 0.0023
288 CACHEXIA 12 0.0023
289 SKIN ABRASION 11 0.0023
290 PANIC DISORDER 9 0.0023
291 HYPERBILIRUBINAEMIA 24 0.0023
292 BLOOD CREATININE ABNORMAL 8 0.0023
293 ORAL INFECTION 9 0.0023
294 PLATELET COUNT INCREASED 30 0.0023
295 AORTIC STENOSIS 8 0.0023
296 RIB FRACTURE 47 0.0023
297 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
298 FEBRILE NEUTROPENIA 151 0.0023
299 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
300 BLOOD UREA INCREASED 38 0.0023
301 BLOOD ALBUMIN DECREASED 18 0.0023
302 PAIN IN JAW 63 0.0022
303 HYPERTRIGLYCERIDAEMIA 13 0.0022
304 PELVIC PAIN 40 0.0022
305 ABDOMINAL HERNIA 10 0.0022
306 LIVER FUNCTION TEST INCREASED 47 0.0022
307 HYPERCHOLESTEROLAEMIA 21 0.0022
308 OSTEOPENIA 33 0.0022
309 ACUTE CORONARY SYNDROME 18 0.0022
310 SENSITIVE SKIN 16 0.0022
311 VIRAL INFECTION 72 0.0022
312 YELLOW SKIN 10 0.0021
313 CHOLESTASIS 41 0.0021
314 TRANSAMINASES INCREASED 47 0.0021
315 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
316 CARDIAC FAILURE CHRONIC 9 0.0021
317 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
318 URINARY RETENTION 70 0.0021
319 POLYNEUROPATHY 25 0.0021
320 FULL BLOOD COUNT ABNORMAL 22 0.0021
321 PERICARDIAL EFFUSION 48 0.0021
322 ANAEMIA 395 0.0021
323 RASH VESICULAR 10 0.0021
324 HYPERTENSIVE CRISIS 23 0.0021
325 METABOLIC DISORDER 12 0.0021
326 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 48 0.0021
327 BLOOD CALCIUM INCREASED 18 0.0021
328 HAEMOGLOBIN DECREASED 210 0.0020
329 CENTRAL NERVOUS SYSTEM LESION 28 0.0020
330 DECREASED INTEREST 12 0.0020
331 PANCREATIC DISORDER 10 0.0020
332 HYPOMAGNESAEMIA 28 0.0020
333 IRON DEFICIENCY 9 0.0020
334 HAEMORRHOIDS 39 0.0020
335 NEUROPATHY PERIPHERAL 190 0.0020
336 THERAPY PARTIAL RESPONDER 31 0.0020
337 EMPHYSEMA 20 0.0020
338 HEPATOCELLULAR INJURY 28 0.0020
339 TOOTH ABSCESS 20 0.0020
340 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
341 DYSURIA 72 0.0020
342 PHLEBITIS 10 0.0020
343 HAIR DISORDER 16 0.0019
344 GROIN PAIN 17 0.0019
345 GASTRITIS EROSIVE 9 0.0019
346 RASH PUSTULAR 14 0.0019
347 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
348 EXERCISE TOLERANCE DECREASED 11 0.0019
349 AFFECTIVE DISORDER 15 0.0019
350 ISCHAEMIC STROKE 34 0.0019
351 BLOOD URINE PRESENT 36 0.0019
352 BUNDLE BRANCH BLOCK LEFT 8 0.0019
353 GINGIVAL PAIN 15 0.0019
354 MUSCULOSKELETAL DISCOMFORT 32 0.0019
355 MOUTH ULCERATION 39 0.0018
356 DEATH 1593 0.0018
357 HEPATIC ENCEPHALOPATHY 17 0.0018
358 TOOTH INFECTION 24 0.0018
359 NOCTURIA 22 0.0018
360 DERMATITIS ACNEIFORM 11 0.0018
361 EAR PAIN 35 0.0018
362 CARDIOTOXICITY 16 0.0018
363 ERYSIPELAS 9 0.0018
364 TOXIC SKIN ERUPTION 18 0.0018
365 HIATUS HERNIA 23 0.0018
366 LIVER FUNCTION TEST ABNORMAL 51 0.0018
367 CEREBRAL ISCHAEMIA 9 0.0017
368 RED BLOOD CELL COUNT DECREASED 50 0.0017
369 HEPATOMEGALY 17 0.0017
370 BREAST TENDERNESS 13 0.0017
371 INJECTION SITE HAEMATOMA 25 0.0017
372 BRAIN FOG 27 0.0017
373 RALES 10 0.0017
374 PRODUCTIVE COUGH 82 0.0017
375 RED BLOOD CELL SEDIMENTATION RATE INCREASED 19 0.0017
376 RENAL DISORDER 80 0.0017
377 TOOTHACHE 31 0.0017
378 FLANK PAIN 16 0.0017
379 BREAST CANCER STAGE III 11 0.0017
380 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
381 PLATELET COUNT DECREASED 180 0.0017
382 GASTROINTESTINAL MOTILITY DISORDER 9 0.0017
383 ODYNOPHAGIA 10 0.0017
384 ANAL INCONTINENCE 15 0.0017
385 OESOPHAGITIS 18 0.0016
386 NIGHT SWEATS 53 0.0016
387 GASTROINTESTINAL PAIN 18 0.0016
388 ELECTROLYTE IMBALANCE 19 0.0016
389 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
390 DEAFNESS UNILATERAL 9 0.0016
391 BRONCHIECTASIS 11 0.0016
392 ATRIAL FLUTTER 13 0.0016
393 UROSEPSIS 15 0.0016
394 INJECTION SITE DISCOMFORT 17 0.0016
395 SENSORY LOSS 13 0.0016
396 MALNUTRITION 18 0.0016
397 NASAL DRYNESS 10 0.0016
398 DRUG-INDUCED LIVER INJURY 50 0.0016
399 LARGE INTESTINE POLYP 11 0.0016
400 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
401 LYMPHOCYTE COUNT DECREASED 28 0.0016
402 POOR QUALITY SLEEP 34 0.0016
403 LIVER DISORDER 70 0.0016
404 VISUAL DISTURBANCE 9 0.0016
405 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
406 DYSPNOEA EXERTIONAL 59 0.0016
407 NEOPLASM 18 0.0016
408 ENTERITIS 10 0.0016
409 APHTHOUS ULCER 12 0.0015
410 EJECTION FRACTION DECREASED 24 0.0015
411 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
412 ANGINA UNSTABLE 10 0.0015
413 MOOD SWINGS 49 0.0015
414 PARALYSIS 22 0.0015
415 TASTE DISORDER 31 0.0015
416 VITAMIN D DECREASED 13 0.0015
417 ERECTILE DYSFUNCTION 39 0.0015
418 DRUG RESISTANCE 39 0.0015
419 WALKING AID USER 10 0.0015
420 RENAL CYST 12 0.0015
421 EPILEPSY 46 0.0015
422 MOOD ALTERED 41 0.0015
423 SPINAL FRACTURE 30 0.0015
424 MUSCLE DISORDER 12 0.0015
425 HEMIPARESIS 25 0.0015
426 LUNG INFILTRATION 13 0.0015
427 LIVER INJURY 36 0.0015
428 POLLAKIURIA 61 0.0015
429 NEPHROTIC SYNDROME 10 0.0015
430 DENTAL CARIES 16 0.0014
431 BLOOD CREATININE INCREASED 94 0.0014
432 ASTHENIA 540 0.0014
433 ORTHOSTATIC HYPOTENSION 25 0.0014
434 STOMATITIS 87 0.0014
435 FEEDING DISORDER 29 0.0014
436 FAECES DISCOLOURED 31 0.0014
437 ANGIOPATHY 8 0.0014
438 CEREBRAL HAEMORRHAGE 51 0.0014
439 HAIR TEXTURE ABNORMAL 19 0.0014
440 INCONTINENCE 15 0.0014
441 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
442 OSTEOPOROSIS 58 0.0014
443 CIRCULATORY COLLAPSE 24 0.0014
444 GENERAL PHYSICAL HEALTH DETERIORATION 163 0.0014
445 IMMUNODEFICIENCY 21 0.0014
446 TORSADE DE POINTES 11 0.0014
447 PROCTALGIA 9 0.0014
448 THROMBOCYTOPENIA 156 0.0014
449 CEREBRAL INFARCTION 34 0.0014
450 HYPOKALAEMIA 64 0.0014
451 TRICUSPID VALVE INCOMPETENCE 11 0.0014
452 PULMONARY EMBOLISM 131 0.0014
453 BONE MARROW FAILURE 28 0.0014
454 C-REACTIVE PROTEIN INCREASED 50 0.0014
455 FRACTURE 26 0.0014
456 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
457 HEPATITIS 35 0.0014
458 PULMONARY CONGESTION 18 0.0014
459 ORAL DISORDER 10 0.0014
460 CORONAVIRUS INFECTION 9 0.0014
461 TENDONITIS 21 0.0014
462 BLOOD TEST ABNORMAL 19 0.0014
463 TENDERNESS 14 0.0013
464 JOINT STIFFNESS 35 0.0013
465 VITAMIN D DEFICIENCY 13 0.0013
466 UVEITIS 18 0.0013
467 SYNCOPE 132 0.0013
468 ANOREXIA 17 0.0013
469 MYOCARDIAL ISCHAEMIA 15 0.0013
470 DECREASED APPETITE 306 0.0013
471 EXOSTOSIS 12 0.0013
472 MICTURITION URGENCY 15 0.0013
473 BACK PAIN 305 0.0013
474 ARRHYTHMIA 62 0.0013
475 BODY HEIGHT DECREASED 14 0.0013
476 BRAIN NEOPLASM 12 0.0013
477 GASTRIC HAEMORRHAGE 15 0.0013
478 RECTAL HAEMORRHAGE 56 0.0013
479 ORAL PAIN 29 0.0013
480 BLOOD POTASSIUM INCREASED 21 0.0013
481 OEDEMA 70 0.0013
482 DEPRESSED MOOD 68 0.0013
483 HAIR COLOUR CHANGES 16 0.0013
484 CARPAL TUNNEL SYNDROME 18 0.0013
485 URINARY INCONTINENCE 38 0.0013
486 GASTROINTESTINAL INFLAMMATION 10 0.0013
487 SQUAMOUS CELL CARCINOMA 12 0.0013
488 CARDIAC FAILURE 102 0.0013
489 NEUTROPHIL COUNT INCREASED 13 0.0013
490 DIVERTICULUM 9 0.0013
491 HYPERGLYCAEMIA 46 0.0013
492 LIMB DISCOMFORT 39 0.0013
493 SKELETAL INJURY 13 0.0013
494 IMPAIRED HEALING 41 0.0012
495 BLOOD DISORDER 10 0.0012
496 SKIN INFECTION 14 0.0012
497 GINGIVAL BLEEDING 17 0.0012
498 MITRAL VALVE INCOMPETENCE 14 0.0012
499 HEPATIC FAILURE 37 0.0012
500 PHARYNGEAL SWELLING 12 0.0012
501 CYTOPENIA 15 0.0012
502 MASS 17 0.0012
503 GENERALISED OEDEMA 15 0.0012
504 PHARYNGITIS 15 0.0012
505 APPETITE DISORDER 8 0.0012
506 DECREASED ACTIVITY 13 0.0012
507 EMBOLISM 10 0.0012
508 SKIN LESION 33 0.0012
509 COGNITIVE DISORDER 56 0.0012
510 HAEMATOMA 31 0.0012
511 FATIGUE 925 0.0012
512 OSTEOARTHRITIS 50 0.0012
513 GASTRITIS 31 0.0012
514 DEFORMITY 11 0.0012
515 ALOPECIA 231 0.0012
516 PALLOR 32 0.0012
517 HYPERTENSION 249 0.0012
518 CONSTIPATION 256 0.0012
519 HYPOKINESIA 17 0.0012
520 HEPATIC CIRRHOSIS 22 0.0012
521 DEVICE RELATED INFECTION 18 0.0012
522 ARTERIOSCLEROSIS 11 0.0012
523 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
524 GASTROENTERITIS 17 0.0012
525 BLOOD POTASSIUM DECREASED 35 0.0012
526 SKIN HYPERPIGMENTATION 10 0.0012
527 CONGENITAL ANOMALY 9 0.0012
528 SPINAL DISORDER 11 0.0012
529 HYPOALBUMINAEMIA 9 0.0012
530 VENTRICULAR EXTRASYSTOLES 12 0.0012
531 RENAL FAILURE ACUTE 49 0.0012
532 HYSTERECTOMY 10 0.0012
533 CARDIOMYOPATHY 17 0.0011
534 NEUROTOXICITY 20 0.0011
535 PULMONARY OEDEMA 51 0.0011
536 JOINT DISLOCATION 12 0.0011
537 DRUG ERUPTION 20 0.0011
538 BODY TEMPERATURE INCREASED 23 0.0011
539 PANCYTOPENIA 63 0.0011
540 TOOTH DISORDER 25 0.0011
541 INFLAMMATION 58 0.0011
542 RASH MACULO-PAPULAR 25 0.0011
543 BREAST CANCER FEMALE 30 0.0011
544 MOVEMENT DISORDER 36 0.0011
545 SUBDURAL HAEMATOMA 16 0.0011
546 OEDEMA PERIPHERAL 136 0.0011
547 MYOSITIS 10 0.0011
548 DISTURBANCE IN ATTENTION 60 0.0011
549 LIGAMENT SPRAIN 11 0.0011
550 PANCREATITIS ACUTE 25 0.0011
551 SEXUAL DYSFUNCTION 13 0.0011
552 ASPHYXIA 9 0.0011
553 SLEEP APNOEA SYNDROME 21 0.0011
554 ARTHRALGIA 457 0.0011
555 GYNAECOMASTIA 34 0.0011
556 CHOLELITHIASIS 36 0.0011
557 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
558 BLOOD GLUCOSE FLUCTUATION 12 0.0011
559 IRON DEFICIENCY ANAEMIA 10 0.0011
560 BLOOD PRESSURE FLUCTUATION 26 0.0011
561 MENTAL DISORDER 47 0.0011
562 PERSONALITY CHANGE 10 0.0011
563 MUSCULAR WEAKNESS 122 0.0011
564 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
565 NEURALGIA 26 0.0011
566 SENSATION OF FOREIGN BODY 9 0.0011
567 FISTULA 12 0.0011
568 SCIATICA 17 0.0011
569 NO THERAPEUTIC RESPONSE 13 0.0011
570 NEOPLASM MALIGNANT 71 0.0011
571 LEUKAEMIA 10 0.0011
572 CARDIOMEGALY 13 0.0011
573 HYPOPHAGIA 27 0.0011
574 BLOOD COUNT ABNORMAL 16 0.0011
575 VISUAL ACUITY REDUCED 35 0.0011
576 CELLULITIS 53 0.0011
577 CYST 13 0.0010
578 ATRIAL FIBRILLATION 102 0.0010
579 PULMONARY FIBROSIS 20 0.0010
580 FLUID RETENTION 53 0.0010
581 RENAL PAIN 11 0.0010
582 MEMORY IMPAIRMENT 142 0.0010
583 DERMATITIS ALLERGIC 13 0.0010
584 EYELID OEDEMA 12 0.0010
585 DIZZINESS POSTURAL 10 0.0010
586 MYALGIA 175 0.0010
587 SWOLLEN TONGUE 32 0.0010
588 COLD SWEAT 18 0.0010
589 PURPURA 9 0.0010
590 HYPOAESTHESIA 152 0.0010
591 ABASIA 25 0.0010
592 BACTERAEMIA 12 0.0010
593 FACE OEDEMA 17 0.0010
594 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
595 FEELING COLD 28 0.0010
596 HAEMORRHAGE 105 0.0010
597 MELAENA 22 0.0010
598 WEIGHT DECREASED 278 0.0010
599 NERVOUSNESS 52 0.0010
600 HIP FRACTURE 32 0.0010
601 SKIN REACTION 14 0.0010
602 VAGINAL DISCHARGE 10 0.0010
603 RHABDOMYOLYSIS 41 0.0010
604 OCULAR DISCOMFORT 11 0.0010
605 LUNG DISORDER 48 0.0010
606 CHROMATURIA 22 0.0010
607 MUSCULOSKELETAL PAIN 51 0.0010
608 HYPOTHYROIDISM 31 0.0010
609 MYELODYSPLASTIC SYNDROME 14 0.0010
610 VAGINAL HAEMORRHAGE 42 0.0010
611 LOWER RESPIRATORY TRACT INFECTION 44 0.0010
612 DIPLOPIA 25 0.0010
613 COAGULOPATHY 16 0.0010
614 HYPERHIDROSIS 123 0.0010
615 HEPATIC ENZYME INCREASED 65 0.0010
616 CATARACT 56 0.0009
617 PRODUCT ADMINISTRATION ERROR 19 0.0009
618 INJECTION SITE HAEMORRHAGE 75 0.0009
619 ABDOMINAL DISTENSION 98 0.0009
620 DEEP VEIN THROMBOSIS 61 0.0009
621 TINNITUS 43 0.0009
622 DYSPEPSIA 92 0.0009
623 SENSORY DISTURBANCE 15 0.0009
624 CONFUSIONAL STATE 151 0.0009
625 DEMENTIA 26 0.0009
626 WOUND 26 0.0009
627 ANURIA 8 0.0009
628 CARDIAC MURMUR 8 0.0009
629 DRUG INTOLERANCE 89 0.0009
630 LETHARGY 53 0.0009
631 HYPERLIPIDAEMIA 11 0.0009
632 SINUS TACHYCARDIA 13 0.0009
633 CYSTITIS 29 0.0009
634 IMMUNE SYSTEM DISORDER 12 0.0009
635 SARS-COV-2 TEST POSITIVE 12 0.0009
636 CRYING 33 0.0009
637 TOOTH FRACTURE 10 0.0009
638 BLADDER DISORDER 9 0.0009
639 URINARY TRACT INFECTION 154 0.0009
640 NERVE INJURY 10 0.0009
641 ACUTE MYELOID LEUKAEMIA 14 0.0009
642 HYPERTHYROIDISM 13 0.0009
643 QUALITY OF LIFE DECREASED 12 0.0009
644 APATHY 13 0.0009
645 ABDOMINAL PAIN 207 0.0009
646 ACUTE MYOCARDIAL INFARCTION 26 0.0009
647 FLATULENCE 50 0.0009
648 INSOMNIA 234 0.0009
649 ANGINA PECTORIS 25 0.0009
650 MYOCARDITIS 10 0.0009
651 MULTI-ORGAN FAILURE 15 0.0009
652 PYREXIA 300 0.0009
653 DIABETES MELLITUS 66 0.0009
654 PAIN IN EXTREMITY 254 0.0009
655 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 29 0.0009
656 BLOOD CHOLESTEROL INCREASED 40 0.0009
657 DISCOMFORT 52 0.0009
658 GAIT DISTURBANCE 163 0.0009
659 SUDDEN DEATH 9 0.0008
660 BLOOD SODIUM DECREASED 16 0.0008
661 EATING DISORDER 18 0.0008
662 SWELLING 79 0.0008
663 BLOOD IRON DECREASED 10 0.0008
664 PROTEINURIA 16 0.0008
665 DRY EYE 42 0.0008
666 DEHYDRATION 112 0.0008
667 SKIN DISORDER 28 0.0008
668 DELIRIUM 29 0.0008
669 MUSCULOSKELETAL STIFFNESS 73 0.0008
670 HEPATIC CANCER 20 0.0008
671 CANDIDA INFECTION 14 0.0008
672 BACK INJURY 9 0.0008
673 PULMONARY THROMBOSIS 9 0.0008
674 CHOKING 16 0.0008
675 INFLUENZA LIKE ILLNESS 67 0.0008
676 DEPRESSION 185 0.0008
677 BLOOD PRESSURE INCREASED 124 0.0008
678 DRUG INTERACTION 128 0.0008
679 DIARRHOEA 520 0.0008
680 ACUTE HEPATIC FAILURE 11 0.0008
681 PAIN 492 0.0008
682 SECRETION DISCHARGE 10 0.0008
683 APHASIA 24 0.0008
684 PARAESTHESIA 125 0.0008
685 DYSPNOEA 449 0.0008
686 ABDOMINAL PAIN LOWER 20 0.0008
687 HEAD DISCOMFORT 14 0.0008
688 HUNGER 11 0.0008
689 NAUSEA 624 0.0008
690 INTERNAL HAEMORRHAGE 9 0.0008
691 WEIGHT INCREASED 176 0.0008
692 THIRST 14 0.0008
693 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
694 PRESYNCOPE 19 0.0008
695 PNEUMONIA 253 0.0008
696 CARDIAC DISORDER 73 0.0008
697 UPPER RESPIRATORY TRACT INFECTION 36 0.0008
698 TOOTH LOSS 16 0.0008
699 INJECTION SITE INDURATION 10 0.0008
700 RESTLESS LEGS SYNDROME 14 0.0008
701 ASTHMA 87 0.0008
702 NECK PAIN 43 0.0008
703 SPLENOMEGALY 9 0.0008
704 CHEST PAIN 142 0.0008
705 FALL 255 0.0008
706 SLEEP DISORDER 54 0.0008
707 COLITIS 29 0.0008
708 PARAESTHESIA ORAL 11 0.0008
709 ATAXIA 9 0.0008
710 DIVERTICULITIS 21 0.0008
711 PNEUMOTHORAX 12 0.0008
712 TACHYCARDIA 67 0.0008
713 ABSCESS 12 0.0008
714 DRUG ADMINISTRATION ERROR 23 0.0007
715 GASTRIC ULCER 14 0.0007
716 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
717 SUICIDAL IDEATION 67 0.0007
718 BONE LOSS 11 0.0007
719 HYPOAESTHESIA ORAL 11 0.0007
720 CORONARY ARTERY DISEASE 22 0.0007
721 SEPSIS 81 0.0007
722 PALPITATIONS 85 0.0007
723 HERNIA 14 0.0007
724 MALAISE 314 0.0007
725 DISEASE RECURRENCE 34 0.0007
726 HYPOXIA 25 0.0007
727 MENSTRUATION IRREGULAR 19 0.0007
728 HEART RATE IRREGULAR 16 0.0007
729 LUNG INFECTION 11 0.0007
730 DIALYSIS 10 0.0007
731 DEVICE DEPLOYMENT ISSUE 9 0.0007
732 METRORRHAGIA 12 0.0007
733 FEELING HOT 43 0.0007
734 VOMITING 328 0.0007
735 SKIN DISCOLOURATION 32 0.0007
736 SHOCK 16 0.0007
737 DYSPHAGIA 66 0.0007
738 FULL BLOOD COUNT DECREASED 14 0.0007
739 ULCER 11 0.0007
740 THERAPY NON-RESPONDER 31 0.0007
741 LOSS OF CONSCIOUSNESS 88 0.0007
742 ABDOMINAL DISCOMFORT 115 0.0007
743 DYSPHONIA 40 0.0007
744 MIGRAINE 65 0.0007
745 HYPOTENSION 136 0.0007
746 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
747 PSYCHOTIC DISORDER 20 0.0007
748 NERVOUS SYSTEM DISORDER 21 0.0007
749 DIZZINESS 335 0.0007
750 COLON CANCER 10 0.0007
751 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
752 GASTROINTESTINAL DISORDER 60 0.0007
753 INJURY 47 0.0007
754 HEADACHE 418 0.0007
755 CONTUSION 64 0.0007
756 RASH PRURITIC 36 0.0007
757 PERIPHERAL SWELLING 102 0.0007
758 HERPES ZOSTER 38 0.0007
759 LIP SWELLING 22 0.0007
760 HYPONATRAEMIA 37 0.0007
761 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
762 MYOCARDIAL INFARCTION 113 0.0006
763 JOINT SWELLING 78 0.0006
764 AGRANULOCYTOSIS 12 0.0006
765 AMNESIA 42 0.0006
766 THINKING ABNORMAL 12 0.0006
767 DELUSION 10 0.0006
768 BACTERIAL INFECTION 12 0.0006
769 RENAL IMPAIRMENT 54 0.0006
770 AGEUSIA 16 0.0006
771 VERTIGO 39 0.0006
772 PARANOIA 11 0.0006
773 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
774 COUGH 178 0.0006
775 RHINORRHOEA 41 0.0006
776 BRAIN OEDEMA 8 0.0006
777 IRRITABILITY 38 0.0006
778 PAIN OF SKIN 17 0.0006
779 CHILLS 74 0.0006
780 ECZEMA 33 0.0006
781 INCREASED APPETITE 12 0.0006
782 CHEST DISCOMFORT 64 0.0006
783 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
784 ANXIETY 177 0.0006
785 RASH GENERALISED 16 0.0006
786 ABDOMINAL PAIN UPPER 126 0.0006
787 NEPHROLITHIASIS 28 0.0006
788 DRY SKIN 81 0.0006
789 PHOTOSENSITIVITY REACTION 10 0.0006
790 HEART RATE DECREASED 21 0.0006
791 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
792 INFECTION 86 0.0006
793 CONJUNCTIVITIS 11 0.0006
794 DEVICE FAILURE 9 0.0006
795 CEREBROVASCULAR ACCIDENT 100 0.0006
796 ACUTE KIDNEY INJURY 89 0.0006
797 MUSCLE SPASMS 106 0.0006
798 BASAL CELL CARCINOMA 9 0.0006
799 RESPIRATORY FAILURE 42 0.0006
800 POST PROCEDURAL COMPLICATION 11 0.0006
801 OROPHARYNGEAL PAIN 53 0.0006
802 GLAUCOMA 11 0.0006
803 MOBILITY DECREASED 41 0.0006
804 OXYGEN SATURATION DECREASED 32 0.0006
805 CONDITION AGGRAVATED 173 0.0006
806 FEELING ABNORMAL 136 0.0006
807 BRADYCARDIA 30 0.0006
808 HEART RATE INCREASED 56 0.0006
809 VISUAL IMPAIRMENT 70 0.0006
810 OFF LABEL USE 493 0.0006
811 MENORRHAGIA 11 0.0006
812 ILL-DEFINED DISORDER 34 0.0006
813 LIMB INJURY 15 0.0006
814 PRESCRIBED UNDERDOSE 11 0.0006
815 NEEDLE ISSUE 16 0.0005
816 THROMBOSIS 44 0.0005
817 VENTRICULAR TACHYCARDIA 9 0.0005
818 AGITATION 40 0.0005
819 DRY MOUTH 44 0.0005
820 BLOOD GLUCOSE ABNORMAL 10 0.0005
821 RASH 236 0.0005
822 INJECTION SITE MASS 20 0.0005
823 HEAD INJURY 17 0.0005
824 HYPOGLYCAEMIA 26 0.0005
825 PERICARDITIS 9 0.0005
826 SPEECH DISORDER 28 0.0005
827 DYSARTHRIA 20 0.0005
828 SCAR 9 0.0005
829 HAEMATOCHEZIA 29 0.0005
830 ERYTHEMA 108 0.0005
831 DYSGEUSIA 39 0.0005
832 ILLNESS 54 0.0005
833 RASH ERYTHEMATOUS 25 0.0005
834 ARTHRITIS 41 0.0005
835 ACUTE RESPIRATORY FAILURE 10 0.0005
836 BLINDNESS 21 0.0005
837 IRRITABLE BOWEL SYNDROME 11 0.0005
838 LUNG NEOPLASM MALIGNANT 21 0.0005
839 BONE DENSITY DECREASED 16 0.0005
840 VISION BLURRED 70 0.0005
841 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
842 EPISTAXIS 38 0.0005
843 ANGER 17 0.0005
844 ROAD TRAFFIC ACCIDENT 21 0.0005
845 HAEMOPTYSIS 14 0.0005
846 SKIN EXFOLIATION 42 0.0005
847 COVID-19 87 0.0005
848 ANHEDONIA 13 0.0005
849 INFLUENZA 55 0.0005
850 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
851 RENAL FAILURE 65 0.0005
852 WHEEZING 29 0.0005
853 ENCEPHALOPATHY 12 0.0005
854 THERAPY CESSATION 25 0.0005
855 EMOTIONAL DISORDER 15 0.0005
856 CARDIAC FAILURE CONGESTIVE 39 0.0005
857 BURNING SENSATION 34 0.0005
858 SEPTIC SHOCK 21 0.0005
859 DYSSTASIA 14 0.0005
860 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
861 HAEMATEMESIS 12 0.0005
862 PRODUCT QUALITY ISSUE 64 0.0005
863 JOINT INJURY 10 0.0005
864 PRODUCT USE IN UNAPPROVED INDICATION 116 0.0005
865 ANAPHYLACTIC SHOCK 12 0.0005
866 SKIN CANCER 10 0.0005
867 PRODUCT USE ISSUE 87 0.0005
868 BALANCE DISORDER 40 0.0005
869 BLOOD GLUCOSE INCREASED 87 0.0005
870 SKIN FISSURES 9 0.0005
871 SEIZURE 53 0.0005
872 DIABETIC KETOACIDOSIS 11 0.0005
873 RASH MACULAR 16 0.0005
874 CONVULSION 26 0.0005
875 FEMUR FRACTURE 14 0.0005
876 UPPER LIMB FRACTURE 9 0.0005
877 INTESTINAL OBSTRUCTION 17 0.0005
878 MEDICATION ERROR 25 0.0004
879 RASH PAPULAR 10 0.0004
880 TYPE 2 DIABETES MELLITUS 15 0.0004
881 PRURITUS 170 0.0004
882 BLOOD PRESSURE DECREASED 29 0.0004
883 TREATMENT FAILURE 36 0.0004
884 GASTRIC CANCER 11 0.0004
885 MENTAL STATUS CHANGES 12 0.0004
886 PULMONARY HYPERTENSION 9 0.0004
887 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
888 NASOPHARYNGITIS 78 0.0004
889 INTENTIONAL DOSE OMISSION 12 0.0004
890 INJECTION SITE BRUISING 33 0.0004
891 SOMNOLENCE 83 0.0004
892 BRONCHITIS 30 0.0004
893 NIGHTMARE 14 0.0004
894 INTENTIONAL PRODUCT MISUSE 35 0.0004
895 ANAPHYLACTIC REACTION 22 0.0004
896 PANCREATITIS 21 0.0004
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
898 ARTHROPATHY 22 0.0004
899 EYE DISORDER 13 0.0004
900 PRODUCT AVAILABILITY ISSUE 9 0.0004
901 BLISTER 22 0.0004
902 TREMOR 65 0.0004
903 SKIN ULCER 10 0.0004
904 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
905 ANGIOEDEMA 17 0.0004
906 PANIC ATTACK 14 0.0004
907 DEAFNESS 10 0.0004
908 INJECTION SITE PAIN 117 0.0004
909 TOXICITY TO VARIOUS AGENTS 64 0.0004
910 COMA 18 0.0004
911 METABOLIC ACIDOSIS 12 0.0004
912 EYE PAIN 21 0.0004
913 MENTAL IMPAIRMENT 9 0.0004
914 SINUSITIS 38 0.0004
915 HYPERKALAEMIA 13 0.0004
916 THROAT TIGHTNESS 10 0.0004
917 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
918 RESPIRATORY DISORDER 11 0.0004
919 STAPHYLOCOCCAL INFECTION 12 0.0004
920 THERAPEUTIC RESPONSE DECREASED 22 0.0004
921 GAIT INABILITY 12 0.0004
922 EYE PRURITUS 12 0.0004
923 HYPERSENSITIVITY 66 0.0004
924 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 64 0.0004
925 DISORIENTATION 14 0.0004
926 SWELLING FACE 23 0.0004
927 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
928 THROAT IRRITATION 15 0.0003
929 FUNGAL INFECTION 11 0.0003
930 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
931 DEVICE MALFUNCTION 23 0.0003
932 RESPIRATORY ARREST 9 0.0003
933 RESPIRATORY DISTRESS 9 0.0003
934 HYPOACUSIS 14 0.0003
935 ABORTION SPONTANEOUS 13 0.0003
936 SURGERY 19 0.0003
937 DEVICE EXPULSION 21 0.0003
938 DYSKINESIA 13 0.0003
939 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
940 HYPERSOMNIA 9 0.0003
941 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
942 PANCREATIC CARCINOMA 9 0.0003
943 CARDIO-RESPIRATORY ARREST 13 0.0003
944 URTICARIA 52 0.0003
945 SKIN BURNING SENSATION 22 0.0003
946 ADVERSE EVENT 28 0.0003
947 RESTLESSNESS 11 0.0003
948 AGGRESSION 15 0.0003
949 EYE SWELLING 11 0.0003
950 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
951 TREATMENT NONCOMPLIANCE 16 0.0003
952 HALLUCINATION 22 0.0003
953 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
954 GASTRIC DISORDER 10 0.0003
955 EXPOSURE DURING PREGNANCY 18 0.0003
956 BLADDER CANCER 17 0.0003
957 SKIN IRRITATION 13 0.0003
958 DRUG INEFFECTIVE 372 0.0003
959 DRUG DOSE OMISSION 46 0.0003
960 EYE IRRITATION 16 0.0003
961 CARDIAC ARREST 22 0.0003
962 ADVERSE DRUG REACTION 23 0.0003
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
964 OCULAR HYPERAEMIA 12 0.0003
965 ABNORMAL BEHAVIOUR 10 0.0003
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
967 UNDERDOSE 18 0.0002
968 ACNE 18 0.0002
969 SUICIDE ATTEMPT 14 0.0002
970 DEVICE DISLOCATION 10 0.0002
971 PRODUCT DOSE OMISSION 15 0.0002
972 PRODUCT DOSE OMISSION ISSUE 67 0.0002
973 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
974 FLUSHING 23 0.0002
975 ACCIDENTAL OVERDOSE 8 0.0002
976 EMOTIONAL DISTRESS 25 0.0002
977 NASAL CONGESTION 12 0.0002
978 HOSPITALISATION 31 0.0002
979 DEVICE ISSUE 17 0.0002
980 INJECTION SITE SWELLING 14 0.0002
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
982 PRODUCT STORAGE ERROR 15 0.0002
983 PRODUCT SUBSTITUTION ISSUE 9 0.0002
984 COMPLETED SUICIDE 13 0.0002
985 THERAPY INTERRUPTED 11 0.0002
986 INJECTION SITE ERYTHEMA 18 0.0001
987 INCORRECT DOSE ADMINISTERED 33 0.0001
988 UNEVALUABLE EVENT 10 0.0001
989 RHEUMATOID ARTHRITIS 15 0.0001
990 CHRONIC KIDNEY DISEASE 9 0.0001
991 PSORIASIS 15 0.0001
992 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
993 OVERDOSE 22 0.0001
994 NO ADVERSE EVENT 14 0.0001